- Home
- GFR vs MNMD Comparison
GFR vs MNMD Comparison
Compare GFR & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFR
- MNMD
- Stock Information
- Founded
- GFR 2018
- MNMD 2019
- Country
- GFR Canada
- MNMD United States
- Employees
- GFR N/A
- MNMD N/A
- Industry
- GFR
- MNMD Pharmaceuticals and Biotechnology
- Sector
- GFR
- MNMD Health Care
- Exchange
- GFR Nasdaq
- MNMD Nasdaq
- Market Cap
- GFR 489.7M
- MNMD 485.5M
- IPO Year
- GFR N/A
- MNMD N/A
- Fundamental
- Price
- GFR $6.09
- MNMD $7.16
- Analyst Decision
- GFR Buy
- MNMD Strong Buy
- Analyst Count
- GFR 1
- MNMD 9
- Target Price
- GFR $10.50
- MNMD $28.75
- AVG Volume (30 Days)
- GFR 104.7K
- MNMD 1.2M
- Earning Date
- GFR 02-14-2025
- MNMD 11-07-2024
- Dividend Yield
- GFR N/A
- MNMD N/A
- EPS Growth
- GFR N/A
- MNMD N/A
- EPS
- GFR 0.40
- MNMD N/A
- Revenue
- GFR $551,353,492.00
- MNMD N/A
- Revenue This Year
- GFR $35.03
- MNMD N/A
- Revenue Next Year
- GFR $37.50
- MNMD N/A
- P/E Ratio
- GFR $15.16
- MNMD N/A
- Revenue Growth
- GFR 11.20
- MNMD N/A
- 52 Week Low
- GFR $4.68
- MNMD $3.46
- 52 Week High
- GFR $8.16
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- GFR 25.40
- MNMD 47.84
- Support Level
- GFR $6.28
- MNMD $6.87
- Resistance Level
- GFR $7.33
- MNMD $8.12
- Average True Range (ATR)
- GFR 0.26
- MNMD 0.52
- MACD
- GFR -0.09
- MNMD -0.07
- Stochastic Oscillator
- GFR 8.82
- MNMD 20.38
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.